• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchBELLUS Health
    Picture of BELLUS Health logo

    BLU — BELLUS Health News Story

    $14.740.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    • Market Cap
      $1.87bn
    • Enterprise Value
      $1.56bn
    • Revenue
      $0.02m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BLU Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BLU Dividends
    All News

    NASDAQ RESUMED

    Picture of BELLUS Health logoBELLUS Health
    05/09/2019 15:02
    NASDAQ RESUMED  BLU.O
    

    Recent news on BELLUS Health

    See all news
    • Brief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition

      16/05/2023 22:30
    • Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights

      12/05/2023 21:03
    • Press Digest: British Business - April 19

      19/04/2023 24:50
    • Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes

      18/04/2023 21:40
    • Bellus soars as GSK plans to buy drug developer for $2 bln

      18/04/2023 15:11

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.